Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022:189:331-358.
doi: 10.1016/B978-0-323-91532-8.00004-5.

Neurologic complications of coronavirus and other respiratory viral infections

Affiliations
Review

Neurologic complications of coronavirus and other respiratory viral infections

Francesco Cavallieri et al. Handb Clin Neurol. 2022.

Abstract

In humans, several respiratory viruses can have neurologic implications affecting both central and peripheral nervous system. Neurologic manifestations can be linked to viral neurotropism and/or indirect effects of the infection due to endothelitis with vascular damage and ischemia, hypercoagulation state with thrombosis and hemorrhages, systemic inflammatory response, autoimmune reactions, and other damages. Among these respiratory viruses, recent and huge attention has been given to the coronaviruses, especially the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in 2020. Besides the common respiratory symptoms and the lung tropism of SARS-CoV-2 (COVID-19), neurologic manifestations are not rare and often present in the severe forms of the infection. The most common acute and subacute symptoms and signs include headache, fatigue, myalgia, anosmia, ageusia, sleep disturbances, whereas clinical syndromes include mainly encephalopathy, ischemic stroke, seizures, and autoimmune peripheral neuropathies. Although the pathogenetic mechanisms of COVID-19 in the various acute neurologic manifestations are partially understood, little is known about long-term consequences of the infection. These consequences concern both the so-called long-COVID (characterized by the persistence of neurological manifestations after the resolution of the acute viral phase), and the onset of new neurological symptoms that may be linked to the previous infection.

Keywords: COVID-19; Coronavirus; Neurology; Respiratory; SARS-CoV-2; Viral infection.

PubMed Disclaimer

Figures

Fig. 17.1
Fig. 17.1
Possible entry routes for SARS-CoV-2 into central nervous system and potential intracellular consequences. There is evidence for SARS-CoV-2 invasion of vasculature in the brain, but little evidence for SARS-CoV-2 in brain parenchyma at this time: this issue will become clearer with results from ongoing autopsy studies. Whether or not the virus is present in neurons or astrocytes, there may be multiple consequences for brain cells, in part through intracellular responses to inflammation that could lead to protein misfolding, a feature of neurodegenerative disorders.

References

    1. Abbott C.A., Baker E., Sutherland G.R., et al. Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics. 1994;40:331–338. - PubMed
    1. Abenza-Abildúa M.J., Ramírez-Prieto M.T., Moreno-Zabaleta R., et al. Neurological complications in critical patients with COVID-19. Neurologia (Engl Ed) 2020;35:621–627. - PMC - PubMed
    1. Abenza Abildúa M.J., Atienza S., Carvalho Monteiro G., et al. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry. Neurologia (Engl Ed) 2021;36:127–134. - PMC - PubMed
    1. Agarwal P., Ray S., Madan A., et al. Neurological manifestations in 404 COVID-19 patients in Washington State. J Neurol. 2021;268:770–772. - PMC - PubMed
    1. Agyeman A.A., Chin K.L., Landersdorfer C.B., et al. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc. 2020;95:1621–1631. - PMC - PubMed